Capgemini saw the highest growth of 0.66% in patent filings in June and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Capgemini’s patent filings and grants. Buy the databook here.
Capgemini has been focused on protecting inventions in United States(US) with nine publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 40% filings and 88% grants. The United States(US), United Kingdom(GB), Spain(ES), and France(FR) patent Office are among the top ten patent offices where Capgemini is filings its patents. Among the top granted patent authorities, Capgemini has 88% of its grants in United States(US) and 12% in France(FR).
Roche and Sanofi could be the strongest competitors for Capgemini
Infusion pumps related patents lead Capgemini portfolio followed by aerospace materials & structural components, and small arms and light weapons
Capgemini has highest number of patents in infusion pumps followed by aerospace materials & structural components, small arms and light weapons, vehicle testing, and shoes & boots.
For comprehensive analysis of Capgemini's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.